Royal Society of Chemistry, Chemical Communications, 26(58), p. 4132-4148, 2022
DOI: 10.1039/d1cc07080k
Full text: Unavailable
Intracellular, allosteric antagonists for chemokine receptors hold great promise for the therapeutic modulation of chemokine responses.